Clinical Trial: Digital Heart Rate Variability Biofeedback Intervention for First Episode Psychosis

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07628699) titled 'Digital Heart Rate Variability Biofeedback Intervention for First Episode Psychosis' on May 14.

Brief Summary: The objective of the current study is to assess the impact of a five-week digital heart rate variability biofeedback (HRV-B) intervention or music listening on the well-being of first episode psychosis patients. Heart rate variability (HRV) is a measure of how an individual's heart rate can adapt to a changing environment and mental and physiological challenges. It has been well established that HRV can be regulated through actions such as slow breathing and meditation. HRV Biofeedback (HRV-B) involves breathing at a specifi...